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Currently, the diagnosis of kidney allograft rejection relies on individual histological
assessments made by expert pathologists according to the Banff classification. In
this study, we applied new Computer-Assisted System Technology (newCASTTM) by
Visiopharm® with the aim of identifying and quantifying the immune cells in inflammatory
infiltrates. We searched for distinctive cellular profiles that could be assigned to each
rejection category of the Banff schema: antibody-mediated rejection (active and chronic
active), borderline, T cell-mediated rejection (TCMR), and mixed rejection. This study
was performed with 49 biopsy samples, 42 from patients with rejection and 7 from
patients with clinical signs of dysfunction but an absence of histological findings of
rejection. Plasma cells, B and T lymphocytes, natural killer cells, and macrophages,
with a special focus on the M1 and M2 subsets, were studied. A major difference
among the Banff rejection groups was in the total amount of cells/mm2 tissue. Principal
component analysis identified some distinctive associations. The borderline category
grouped with CD4+ lymphocytes and M1 macrophages, and active antibody-mediated
rejection (aAMR) clustered with natural killer cells. Despite these findings, the search for
characteristic profiles linked to the rejection types proved to be a very difficult task since
the cellular composition varied significantly among individuals within the same diagnostic
category. The results of this study will be analyzed from the perspective of reconciling
the classic way of diagnosing rejection and the immune situation “in situ” at the time
of diagnosis.
Keywords: inflammatory infiltrate, newCAST, antibody-mediated rejection, borderline diagnostic, banff kidney
classification, biopsy findings, M1 macrophages
INTRODUCTION
Clinical and subclinical rejections are the major causes of kidney allograft loss, and some types
of rejection are difficult to diagnose and are detected late after the onset of the rejection process.
Cellular analysis of the inflammation within a graft provides important information for a more
precise diagnosis, but so far, this approach has not been incorporated into clinical practice.
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The first Banff classification for kidney allograft pathology,
where experts came up with consensus diagnostic criteria, was
published in 1993 and has been updated periodically since then
(1). Some of the categories are well-characterized, but others
are challenging. Among these categories, the process classified
as borderline is not well-defined. At the first Banff meeting,
this category was defined as mild focal interstitial inflammation
and tubulitis with histological findings suggestive of a very
mild acute rejection. At that time, several studies found that
only a subset of patients diagnosed with borderline changes
responded to antirejection therapy, raising questions regarding
the heterogeneity of the processes included in the same group
(2). Therefore, the question is whether the borderline category
should be eliminated or at least redefined. With this purpose
in mind, during the last Banff meeting in Barcelona, a series
of histological and molecular studies were proposed to better
organize this classification system (3).
An important aspect that has not been exhaustively addressed
is the cellular composition of the inflammatory infiltrates in a
biopsy at the time of the diagnosis of rejection. For instance,
it has been demonstrated that macrophages have an important
role as intermediaries between the allograft and T cells in the
initiation of the alloimmune response (4). Macrophages are
functionally heterogeneous and are mainly shaped by a variety
of microenvironmental stimuli that drive polarization toward
the M1 or M2 phenotype, both of which are related to specific
functions. These two states are the two extremes of a phenotypic
continuum dynamically influenced by the milieu (5). The aim
of this study was to identify and quantify the main cell types
present in the inflammatory infiltrates of patients with different
diagnoses of rejection in accordance with the Banff criteria. For
that purpose, we performed immunohistochemistry and double
immunofluorescence staining with relevant cellular markers.
For the analysis, we used a new Computer-Assisted Stereology
method (newCASTTM) with the aim of assigning cellular profiles
to each rejection type included in the Banff classification, with
special emphasis on the less-known borderline category.
Our hypothesis posits that not only the abundance but also
the equilibrium among the components of the inflammatory
infiltrate determine what forces prevail to drive the immune
response toward one kind of rejection or another. This
fragile equilibrium can be altered by many factors, from
inadequate immunosuppression to signals associated with the
innate immune response to infections. For this reason, detailed
knowledge of the whole immune composition captured at the
moment of diagnosis could certainly contribute to a more
precise classification.
MATERIALS AND METHODS
Patients
A cohort of 57 kidney transplant recipients was included in this
study. The kidney transplantations were performed at Hospital
Universitario Virgen del Rocío, Seville, Spain, between 2001 and
2014. Biopsy samples were always harvested in response to a
clinical indication and not solely for the purpose of this study.
In total, 78 samples were analyzed, and all of them were
anonymized and handled according to the ethical guidelines
of the current Declaration of Helsinki, with the approval of
the Hospital Universitario Virgen del Rocío ethical committee.
Informed consent for publication was obtained from the patients.
Seventeen of the samples did not show histological signs of
rejection (NR), and 61 fulfilled the diagnostic criteria for one
of the immune-mediated post-transplant pathologies: active
antibody-mediated rejection (aAMR), chronic active antibody-
mediated rejection (cAMR), T cell-mediated rejection (TCMR),
mixed rejection (MR), or borderline (BL). Diagnoses were made
by expert pathologists following the Banff criteria. All patients
received steroid-based immunosuppression plus tacrolimus and
mofetil mycophenolate (Table 1).
Cell Markers
Cells were immunohistochemically identified with the following
markers: CD20 for B lymphocytes, CD138 for plasma cells, CD4
or CD8 for T lymphocytes, CD56 for NK cells, and FoxP3
for T regulatory cells. Macrophages were immunofluorescence-
stained with an anti-human CD68 antibody and pSTAT1 or
cMAF, which are transcription factors localized in the nuclei
of M1 and M2 macrophages, respectively (6). All antibodies
used and their respective dilutions are summarized in the
Supplementary Table 1.
Immunohistochemistry
Serial sections of three-micrometer-thick formalin-fixed,
paraffin-embedded tissue sections were handled as described (7).
Incubation conditions for the primary antibodies are included
in Supplementary Table 1. EnVisionTM system-horseradish
peroxidase (HRP)-labeled polymer anti-mouse (Dako, ref.
K4000) for mouse primary antibodies and EnVisionTM
system-HRP-labeled polymer anti-rabbit (Dako, ref. K4011)
for rabbit primary antibodies were incubated for 40min at
room temperature.
For the negative controls, the same protocols were
followed, but the primary antibody was omitted to avoid
non-specific signals.
Immunofluorescence
Macrophages and the polarized subpopulations M1 andM2 were
identified by immunofluorescence staining with the primary
anti-pSTAT1 and anti-cMAF rabbit antibodies, respectively. An
Alexa Fluor R© 568-conjugated goat anti-rabbit antibody (Life
Technologies, ref. A11011) in combination with anti-CD68
primary antibody and then an Alexa Fluor R© 488-conjugated goat
anti-mouse (Life Technologies, ref. A11001) were incubated with
the sections at a 1:500 dilution for 30min at RT.
New Computer-Assisted System
Technology
The renal cortex was exhaustively evaluated by employing a
stereological method that avoids observer subjectivity using
new Computer-Assisted System Technology (newCASTTM)
by Visiopharm R©. The newCASTTM stereology system was
previously used in other transplant pathologies (7). To our
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TABLE 1 | Characteristics of patients included in the study.
Characteristics Total number of
patients i-score
analysis (n = 57)
Total number of
patients
newCAST
technology
analysis (n = 36)
Mean recipient age 44 (12–73)
Female 21 (37%)
Male 36 (63%)
First renal transplant 44 (77%)
Second renal transplant 10 (18%)
Third renal transplant 3 (5%)
Donation after cardiac death 49 (86%)
Donation in asystole 3 (5%)
Living donor 5 (9%)
Etiology of ESRD
Nephroangiosclerosis 4 (7%)
Diabetic nephropathy 1 (2%)
Unknown kidney disease 20 (35%)
Chronic tubuloint nephropathy 11 (19%)
Glomerulonephritis 10 (18%)
Systemic 1 (2%)
Polycystic kidney disease 7 (12%)
Congenital nephropathy 3 (5%)
Baseline immunosuppression
ST+ calc. inhib +MMF 50 (88%)
ST+ calc. inhib + mTOR inhib 2 (3%)
ST + mTOR inhib + MMF 5 (9%)
Preformed DSA Class I/II 0
De novo DSA Class I 2 (4%)
De novo DSA Class II 7 (12%)
Total number of biopsies 78 49
Non-rejection 17 (22%) 7 (14%)
Rejection 61 (78%) 42 (86%)
Active antibody-mediated 15 (19%) 11 (26%)
Chronic active antibody-mediated 18 (23%) 15 (36%)
Borderline 17 (22%) 10 (24%)
T cell-mediated 4 (5%) 1 (2%)
Mixed 7 (9%) 5 (12%)
ESRD, end-stage renal disease; ST, steroids (prednisone or methylprednisolone);
calc. inhib, calcineurin inhibitors (cyclosporine or tacrolimus); MMF, mofetil
mycophenolate; mTOR inhib, mTOR inhibitors (sirolimus or everolimus); DSA,
HLA donor-specific antibodies. Bold highligts the total number of biopsies included on
each part of the study.
knowledge, this work is the first application in human kidney
transplantation. The mean sample tool was used following
Visiopharm R© protocols and recommendations (http://www.
visiopharm.com); a super image of the whole slide was captured
at the beginning (Figure 1A). The operator then manually
excluded the medulla and other non-relevant areas in terms
of clinical significance. The tissue sample was outlined as
the region of interest (ROI) and indicated by a green dotted
line (Figure 1B). The computer-assisted software selected areas
within the ROI by systematic random sampling (gray squares)
and analyzed them in a 400x magnification field of view
(Figures 1C,D). A total of 30% of the ROI was assessed by
computer-assisted random sampling. This approach identified
the optimal percentage accepted to achieve statistically sufficient
precision in cell quantification. Double-immunofluorescence
staining identification was supported by ImageJ software, where
double-positive CD68+/pSTAT1+ and CD68+/cMAF+ cells
were identified in the ROI (Figures 1E,F). The quantification of
every cell type included in the study is represented as cells/mm2.
Statistical Analysis
The normality of the data was tested using the Kolmogorov-
Smirnov assay. Due to non-normally distributed data, the
median with interquartile range (IQR) was represented unless
otherwise indicated. Data were analyzed using Mann-Whitney
and Kruskal-Wallis tests for non-parametric variables. A chi-
square test for categorical variables was used. The results were
considered statistically significant when p values were < 0.05.
GraphPad Prism R© Software (La Jolla, California, USA) was used
for representation of the results.
RESULTS
Among 78 biopsies corresponding to 57 kidney transplants, 61
fulfilled the diagnostic criteria for different rejection categories
and were distributed as follows: 15 aAMR biopsies, 18 cAMR
biopsies, 17 BL biopsies, 4 TCMR biopsies, and 7 MR biopsies.
The remaining 17 biopsies, performed due to renal dysfunction,
did not show histological signs of rejection and were used as
the non-rejection group (NR). All these biopsies were classified
with the Banff schema, but only 49 of them were analyzed with
newCASTTM due to a shortage of tissue samples. Demographic
data are detailed in Table 1.
Analysis of Graft Inflammation With
newCASTTM
We identified relevant cell types present in the interstitium and
glomeruli of the renal cortex. Inflammatory cells were negligible
in the glomeruli; therefore, the data presented refer only to
the interstitium. Notably, the mean values of the total number
of cells, including every type, correlated well with the mean
inflammation profile of the total Banff score for each rejection
group, confirming the strength of our method (Figure 2). The
scores for the parameters included as diagnostic criteria by the
Banff Working Group in the biopsies included in our study are
summarized in the Supplementary Figure 1.
Phenotypes of Infiltrating Cells in Different
Categories of Banff Kidney Allograft
Rejection
The characteristics of the biopsies included in this study are
detailed inTable 2. The quantification of the cells in the infiltrates
of the different Banff diagnostic category groups and the non-
rejection group is shown in Figure 3. The data are represented
as the mean number of each type of immune cell/mm2 of tissue.
The infiltrates in the NR biopsies had the lowest number of cells
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FIGURE 1 | Quantification method using newCASTTM Visiopharm® software. Representative images showing super image capture of a biopsy sample (A); manual
outlining of the region of interest (ROI) excluding non-clinically relevant areas, indicated by the green dotted line (B); unbiased random sampling (C); detailed cell
quantification at 400x magnification (D). Double-immunofluorescence staining for CD68 and pSTAT1 (E) or cMAF (F).
FIGURE 2 | Comparison of two approaches to diagnosing rejection. Mean value of inflammation in every diagnostic category measured by the Banff score from 0 to 3
(A) and with the computer-assisted quantification technique performed in this study (B).
(975 cells/mm2), followed by those in the aAMR and cAMR
biopsies, with 1,506 cells/mm2 and 1,598 cells/mm2, respectively.
The borderline category had 2,694 cells/mm2, a value that was
almost double the value for the AMR categories but was still lower
than that of the MR category, which had the highest value of all,
4,032 cells/mm2.
With the purpose of defining profiles that could uncover
specific features among the diagnostic categories of the Banff
classification, we performed a close analysis of the cellular
composition in each of the rejection type groups and the
non-rejection group (Figure 4, Supplementary Table 2). The
main observation was the predominance of T lymphocytes and
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TABLE 2 | Description of the biopsies included in the study.
Banff category
patient code
Biopsy (time
after Tx)
Diagnosis HLA-DSA C4d
Normal Biopsy
NR-1 8 d Non-rejection Neg Neg
NR-2 12 d Non-rejection Neg Neg
NR-3 30 d Non-rejection Neg Neg
NR-4 24 d Non-rejection Neg Neg
NR-5 18 d Non-rejection Neg Neg
NR-6 4 y Non-rejection Neg Neg
NR-7 4m Non-rejection Neg Neg
Active Amr
aAMR-1 (B1) 9 d aAMR grade I Class I +
(B2) 16 d aAMR grade II Class I +
aAMR-2 (B1) 19 d aAMR grade I Class I +
(B2) 5m aAMR grade II Class I +
aAMR-3 8 y aAMR grade II Class I +
aAMR-4 12 d aAMR grade II Class I +
aAMR-5 25 d aAMR grade I Class I +
aAMR-6 3m aAMR grade II Neg +
aAMR-7 19 y aAMR grade II Class II +
aAMR-8 11 y aAMR grade II Class II +
aAMR-9 5 y aAMR grade II Non-HLA +
Chronic Amr
cAMR-1 14 y TxG Neg Neg
cAMR-2 9 y TxG Neg Neg
cAMR-3 6 y TxG Non-HLA +
cAMR-4 (B1) 13 y TxG Class II Neg
(B2) 14 y TxG Class II Neg
cAMR-5 12 y TxG Neg Neg
cAMR-6 6 y TxG Neg Neg
cAMR-7 6 y TxG Class II Neg
cAMR-8 26 y TxG Neg Neg
cAMR-9 11 y TxG Neg Neg
cAMR-10 16m TxG Class II Neg
cAMR-11 10 y TxG Neg Neg
cAMR-12 21m TxG Class II Neg
cAMR-13 10 y cAMR grade
III
Class I +
cAMR-14 5 y cAMR grade
III
Class II +
Borderline
BL-1 6 y Borderline Neg Neg
BL-2 8 d Borderline Neg Neg
BL-3 1 y Borderline Neg Neg
BL-4 4 y Borderline Neg Neg
BL-5 30 d Borderline Neg Neg
BL-6 (B1) 40 d Borderline Neg Neg
(B2) 60 d Borderline Neg Neg
BL-7 3m Borderline Neg Neg
BL-8 8m Borderline Neg Neg
BL-9 18 d Borderline Neg Neg
Tcmr
TCMR-1 5 d TCMR IIB Neg Neg
(Continued)
TABLE 2 | Continued
Banff category
patient code
Biopsy (time
after Tx)
Diagnosis HLA-DSA C4d
Mixed Rejection
MR-1 2 y aAMR II/BL Class I/II +
MR-2 90 d aAMR
II/TCMR IIA
Neg +
MR-3 6 y aAMR
II/TCMR
IIB//TxG
Class I/II +
MR-4 30 d aAMR I/BL Neg +
MR-5 1 y aAMR I/BL Class II +
NR, non-rejection; aAMR, active antibody-mediated rejection; cAMR, chronic active
antibody-mediated rejection; BL, Borderline; MR, mix rejection; TxG, transplant
glomerulopathy; TCMR, T cell-mediated rejection; d, days; m, months; y, years; DSA,
donor-specific HLA antibodies.
macrophages, covering 86–93% of the infiltrates, with CD4 as
the most abundant T-cell population in all the groups studied.
After assessing these two populations, the rest of the cell types
assayed comprised very small proportions of the infiltrates (7–
14%). A detailed description of each profile is given in the
Supplementary Figures 2–6.
Significant Differences Among the Banff
Rejection Groups
The total number of cells identified by each cell marker was
compared among the 5 groups included in the study, and
the results obtained are shown in Figure 5. TCMR is a very
uncommon diagnosis at our hospital and was excluded from
this analysis. Most of the markers assayed seemed useful for
comparing rejection groups, except CD56+ natural killer (NK)
cells, which were not discriminatory for any of the rejection
groups (Figure 5F). The first thing that caught our attention
was the lack of significant differences between NR and aAMR
for all the cell types analyzed. Curiously, the two groups with
a strong humoral component, aAMR and cAMR, showed a
significant difference in the amount of CD138+ plasma cells (p
< 0.05) (Figure 5B). In the BL group, where an important role
for T cells has been suggested, significant differences were seen
from the aAMR and MR groups in terms of the amount of
CD4+ cells and from the MR group in terms of the amount of
FoxP3+ cells, while the amount of CD8+ cells did not distinguish
the BL group from any of the other groups (Figures 5C–E).
An additional discriminating feature between BL and cAMR
was the substantial presence of CD20+ B lymphocytes (p <
0.05) (Figure 5A). MR showed augmented numbers of all three
T lymphocyte types tested, CD4+, CD8+, and FoxP3+ (p <
0.01). Similar to the contrast between BL and cAMR, CD20+
B lymphocytes were a distinguishing feature between MR and
cAMR (p < 0.05).
Regarding macrophages, we first compared the total amount
of macrophages and then the non-polarized, M1, and M2
subsets separately among the rejection groups. The first analysis
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FIGURE 3 | Total cell counts in diagnostic biopsies of rejection. Cell quantification of the inflammatory infiltrates showing cell type composition. The numbers for each
cell type represent the mean values obtained from a group of patients within each rejection category. CD20+ B lymphocytes, CD138+ plasma cells, CD4+ T
lymphocytes, CD8+ T lymphocytes, T regulatory cells FoxP3+, CD68+ (distributed as non-polarized, M1 and M2), and CD56+ natural killer cells were assessed. *The
data for B lymphocytes and plasma cells are missing in the TCMR group due to the low number of tissue samples. The mean numbers of each cell type/mm2 tissue
are shown below each group.
showed statistically significant differences between cAMR and
BL and between cAMR and MR (Figure 5G) that persisted
when the analysis was performed with the non-polarized
population (Figure 5H). However, the most interesting results
appeared when the analysis was performed with the polarized
populations; the first finding was the strong presence of
proinflammatory M1 macrophages in BL, which exhibited
higher M1 macrophage infiltration than the rest of the groups,
although this difference only reached statistical significance
between BL and aAMR (Figure 5I). Since BL is not a well-
characterized entity, the presence of such a high number
of M1 macrophages could be a specific marker for this
pathology that deserves further study. The second finding
was the abundance of M2 macrophages in MR, although this
difference achieved statistical significance only between MR and
cAMR (Figure 5J).
Differences Between TCMR and BL
At the time that the Banff 2015 meeting was held, there was a
working group dedicated to improving the diagnosis of “pure”
TCMR, with the reintroduction of the i-IFTA score as one of
the aspects under consideration (8). The working group was
also evaluating the possible elimination of BL from the Banff
classification. The next update published in 2017 maintained
both TCMR and BL, not as separate categories but as one group
with overlapping features. We found that the amount of T
lymphocytes/mm2 tissue in TCMR and BL was exactly the same
(1,201 vs. 1,207, respectively) but that the composition differed
(914 vs. 725 for CD4+; 260 vs. 433 for CD8+; and 27 vs. 49 for
FoxP3, respectively). Regarding macrophages, BL showed 4 times
more M1 cells (179 vs. 48, respectively) and almost double the
number of M2macrophages (191 vs. 102, respectively) compared
to TCMR (see Figure 3).
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FIGURE 4 | Cellular profiles of the inflammatory infiltrates in diagnostic biopsies of four rejection types included in the Banff classification and a non-rejection type.
Cell Composition in Follow-Up Biopsies
After Therapy
We had the opportunity to compare changes in the cellular
composition after rejection therapy in well-characterized
consecutive biopsies from two patients. The first patient, cAMR-
4, was diagnosed 13 years after transplantation, and a second
biopsy was performed 9 months after diagnosis. There were no
remarkable changes in cell composition, with the exception of
B lymphocytes, which increased from 4 to 8% in the second
biopsy. The number of cells decreased in all cellular types,
especially CD4+ and CD8+, except B lymphocytes and M2
cells (Figure 6A). The second patient, BL-6, was diagnosed
with BL 40 days after transplantation and had a second biopsy
performed 20 days after diagnosis. In the second biopsy, we
observed two important changes. Although the proportion of
total macrophages was essentially unchanged, 58% vs. 64%,
M1 cells diminished from 15 to 7% in favor of M2 cells,
which increased from 10 to 13%, and especially in favor of
non-polarized macrophages, which increased from 33 to 44%.
The second remarkable change was the loss of 1/3 of the CD4+
T lymphocytes, whose proportion decreased from 30 to 20%.
CD8+ cells experienced an increase from 8 to 11%. Tregs, PCs,
and B lymphocytes did not change substantially and maintained
a low number of cells in both biopsies. If we looked at the
total number of cells, CD4+ and M1 cell numbers decreased
in the second biopsy while the numbers of non-polarized and
M2 macrophages was augmented. The number of CD8+ cells
increased, and PCs, B lymphocytes, NK cells, and Tregs remained
practically unchanged, but these cells comprised a very small
proportion of the infiltrates (Figure 6B).
Global Analysis of the Immune Response
in the Banff Categories of Rejection
When taking all cellular types into account, the rejection
category groups and the control group segregated quite well. A
multidimensional scaling plot revealed the clustering of cellular
types with certain diagnostic entities, as shown in Figure 7.
PC2 had large positive associations with NR and BL and
negative associations with aAMR, MR, and cAMR; therefore,
PC2 differentiates the NR and BL categories (upper) from the
aAMR, MR, and cAMR categories (lower), suggesting that the
correlations between NR and BL and among aAMR, MR, and
cAMR are stronger than other correlations, probably because
of the participation of a true rejection process in terms of
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FIGURE 5 | Comparison of the number of cells/mm2 tissue among Banff
rejection categories. CD20+ B lymphocytes (A), CD138+ plasma cells (B),
CD4+ T lymphocytes (C), CD8+ T lymphocytes (D), FoxP3+ T regulatory cells
(E), CD56+ natural killer cells (F), total CD68+ φ (G), non-polarized φ (H), M1
φ (I), and M2 φ (J). The results are presented as the median with the
interquartile range. *p < 0.05, **p < 0.01. Values plotted as individual black
dots represent outliers that fell outside of the upper whisker (the 75th
percentile) or the lower whisker (the 25th percentile).
inflammation in aAMR, MR, and cAMR. PC1 did not show any
association withMR or BL but had positive correlations with NR,
aAMR, and cAMR.
A clustering analysis was performed based on the entities that
were placed close to one another. This analysis demonstrated
that differences exist between the 5 groups included in the study.
Some clusters and trends could be identified: BL clustered with
CD4+ cells andM1macrophages; cAMR clustered with CD138+,
FoxP3+, and CD4+ cells; MR clustered with CD20+ and CD8+;
and finally, aAMR clearly clustered with NK cells. Although the
number of NK cells in the aAMR biopsies did not show any
significant difference from that in the other biopsies when the
mean values were compared, in this analysis, we were able to
confirm that NK cells and aAMR cluster together and that both
entities showmore similarities between them than with any other
category of rejection. Macrophages in general and the M2 subset
clustered with NR and not with any other category, whereas
the M1 subset appeared closest to BL, and, consistent with the
results of this study, we believe that M1 cells should also be
included in this cluster together with CD4+ cells. The same type
of analysis was done in order to correlate Banff lesions with
interstitial infiltrating cells but no clear associations were found
(Supplementary Figure 7).
Changes in the Inflammatory Infiltrates
With Time
In order to see whether the changes in the composition of
the infiltrates were time-dependent regardless of histological
diagnoses, we analyzed the numbers of the interstitial infiltrating
cells in different time periods. We started by considering only
two periods, <1 and >1 year, and compared the values of each
type of cells separately and the total number. There was a higher
number of plasma cells (p = 0.0004) (Figure 8A) and a trend
for a lower number of M2 macrophages (p = 0.066) in biopsies
performed after the first year (Figure 8C). In a second approach,
we divided the biopsies into four periods of time: <1, 1–5,
5–10, and >10 years. The increase in the number of plasma
cells in biopsies at >1 year was confirmed, especially in the
period 1–5 years (p = 0.0043) (Figure 8B). Differences in the
amount of M2 macrophages became statistically significant (p =
0.0055) (Figure 8D). Neither the other cell types nor the global
number of cells showed differences with regard to the period
of time in which the biopsy was performed after the transplant
(Supplementary Figure 8).
DISCUSSION
This is, to our knowledge, the first study that has examined
the number of cells and the composition of the inflammatory
infiltrates in several kidney rejection categories of the Banff
classification by utilizing an innovative newCASTTM-based
approach. This method has the limitation that it requires many
tissue samples, but it represents an objective tool that makes it
possible to compare biopsies with different diagnoses regardless
of the size of the tissue sample. The main advantage would
be to support a correct diagnosis, which, in most cases, is
challenging, but equally important is the opportunity to analyze
in situ the players in the immune response and to understand the
mechanisms of rejection.
In previous years, several authors have quantified lymphocytes
or macrophages by different methods, mainly through counting
cells in “high-power fields” (HPF), either visually (9) or
automatically by utilizing Histoquest software-based analysis
of digital pictures (10). Alternative methods to count cells by
direct observation under a microscope with a 40x lens, either
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FIGURE 6 | Changes in the interstitial infiltrates over time. Comparison of the amount of cells between two consecutive biopsies from a patient with cAMR (A) and a
patient with BL diagnosis (B).
FIGURE 7 | Principal component analysis (PCA) scatterplot of cellular types of
the inflammatory infiltrates among different Banff rejection categories.
Clustering of the most similar entities among the rejection categories and all
the cellular components is shown. PC1 and PC2 are the two principal
component axes. NR, non-rejection; BL, borderline; aAMR, active
antibody-mediated rejection; cAMR, chronic active antibody-mediated
rejection; MR, mixed rejection.
in the entire tissue or in selected areas of interest such as
glomeruli, have been described (11, 12). More recently, the
digitalization of scanned images has facilitated analyses with the
use of different platforms. By computer-assisted analysis of graft
inflammation in a group of AMR patients, Sicard et al. were
able to define predictive factors for allograft loss such as the
quantity of interstitial macrophages (13). Similarly, Bräsen et al.
found that macrophage density in early surveillance biopsies had
a predictive value for allograft loss but, counting macrophage
density in early surveillance biopsies, would require (14), but
it would require protocol biopsies, which are not performed in
some hospitals. Our aim was to understand the events leading
to rejection in each Banff category based on the knowledge
of the cellular composition of the inflammatory infiltrates. We
are conscious of the limitations of the present study, in which
some of the rejection categories were not sufficiently represented.
Nevertheless, we believe that this study has uncovered important
findings. An ample number of markers of adaptive immunity,
such as T and B lymphocytes and plasma cells, have been
analyzed, but so also have markers of innate immunity such
as macrophages and natural killer cells that have recently been
investigated as having much more important roles in transplant
rejection than previously thought (15, 16). In this sense, a
very recent study by Yazdani et al., using transcriptomic data
from AMR and TCMR patients, confirmed a role for NK
cells in AMR by demonstrating significant enrichment of genes
expressed in CD56+ NK cells in AMR. The main contribution
of this study was that activated NK cells are the only cell type
that discriminates between AMR and TCMR (17). Although
our quantification study revealed that NK cells were almost
undetectable and that the number of NK cells/mm2 was similar
across all the rejection categories and the non-rejection group,
principal component analysis revealed a remarkable clustering of
aAMR and NK cells, which agrees with previous evidence for NK
involvement in aAMR (15, 18). Moreover, a major innovation of
this study was the characterization of macrophages, either non-
polarized or polarized toward a proinflammatory state (M1) or a
tissue-repair state (M2). As previously described, macrophages
are able to switch their phenotype and function depending
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FIGURE 8 | Quantitative changes of some cell types depending on the time of biopsy. On the left side, comparison was made between two groups: <1 year and >1
year. On the right side, the >1 year period was subdivided into three groups: 1–5, 5–10, and >10 years. Differences in plasma cells (p = 0.0004) (A) and a trend in M2
macrophages (C) were observed. On the right side, both cellular markers were significantly different (B,D).
on the surrounding conditions. M1 macrophages are activated
by signals provided by Th1 cells and are involved in chronic
inflammation, while M2 macrophages are regulatory cells and
produce anti-inflammatory cytokines (19). Based on our results,
M1 macrophages clustered with BL, and we believe that the
presence of such a high number of M1 macrophages could be
a specific feature of BL that should be explored further. In
addition, M2 cells may have a relevant role in MR, as these
cells are found at higher levels in MR than in other rejection
categories. Macrophage graft infiltration has been correlated with
an increased incidence of chronic rejection (20, 21) as well
as humoral rejection, as macrophage infiltration is significantly
elevated in these categories (14). While aAMR cases and some
cAMR cases have similar features, in this study, we found an
important difference. T cells are the predominant cell type
in cAMR, especially CD4+ cells, which were present in an
amount double that of CD8+ cells, whereas macrophages are the
predominant cell type in aAMR, supporting the results obtained
by Magil in the glomeruli (12).
The main goal of the study was to understand the
significance of the inflammatory infiltrates in biopsies. By using
a computer-assisted stereology method, we determined immune
profiles and found significant differences among the Banff
rejection categories, principally regarding macrophage and T-cell
populations. One of the main conclusions is that the absolute
number of cells is crucial, but there is still an open question
about what factors are able to alter the equilibrium of the cellular
components in each case and drive the immune response to
one form of rejection or another. In the coming years, these
findings should be evaluated and replicated in a significantly
higher number of patients in order to advance in the search for
distinctive cellular profiles linked to different types of rejection.
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